FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 351:1296-1305 September 23, 2004 Number 13 Next

	Full Text PDF PDA Full Text PowerPoint Slide Set Editorial by Hostetter, T. H. Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

ABSTRACT

Background End-stage renal disease substantially increases the risks of death, cardiovascular disease, and use of specialized health care, but the effects of less severe kidney dysfunction on these outcomes are less well defined.

Methods We estimated the longitudinal glomerular filtration rate (GFR) among 1,120,295 adults within a large, integrated system of health care delivery in whom serum creatinine had been measured between 1996 and 2000 and who had not undergone dialysis or kidney transplantation. We examined the multivariable association between the estimated GFR and the risks of death, cardiovascular events, and hospitalization.

Results The median follow-up was 2.84 years, the mean age was 52 years, and 55 percent of the group were women. After adjustment, the risk of death increased as the GFR decreased below 60 ml per minute per 1.73 m² of body-surface area: the adjusted hazard ratio for death was 1.2 with an estimated GFR of 45 to 59 ml per minute per 1.73 m² (95 percent confidence interval, 1.1 to 1.2), 1.8 with an estimated GFR of 30 to 44 ml per minute per 1.73 m² (95 percent confidence interval, 1.7 to 1.9), 3.2 with an estimated GFR of 15 to 29 ml per minute per 1.73 m² (95 percent confidence interval, 3.1 to 3.4), and 5.9 with an estimated GFR of less than 15 ml per minute per 1.73 m² (95 percent confidence interval, 5.4 to 6.5). The adjusted hazard ratio for cardiovascular events also increased inversely with the estimated GFR: 1.4 (95 percent confidence interval, 1.4 to 1.5), 2.0 (95 percent confidence interval, 1.9 to 2.1), 2.8 (95 percent confidence interval, 2.6 to 2.9), and 3.4 (95 percent confidence interval, 3.1 to 3.8), respectively. The adjusted risk of hospitalization with a reduced estimated GFR followed a similar pattern.

Conclusions An independent, graded association was observed between a reduced estimated GFR and the risk of death, cardiovascular events, and hospitalization in a large, community-based population. These findings highlight the clinical and public health importance of chronic renal insufficiency.

Source Information

From the Division of Research, Kaiser Permanente of Northern California, Oakland (A.S.G., D.F.); and the Departments of Epidemiology and Biostatistics (A.S.G., G.M.C., C.E.M.) and Medicine (A.S.G., G.M.C., C.-y.H.), University of California, San Francisco, San Francisco.

Address reprint requests to Dr. Go at the Division of Research, Kaiser Permanente of Northern California, 2000 Broadway, 3rd Fl., Oakland, CA 94612-2304, or at alan.s.go{at}kp.org.

Full Text of this Article

Related Letters:

Chronic Renal Disease and Cardiovascular Risk
Risch L., Sagmeister M., Huber A., Cheng H., Go A. S., Chertow G. M., Hsu C.-y., Anavekar N. S., McMurray J. J.V., Pfeffer M. A.
Extract | Full Text | PDF  
N Engl J Med 2005; 352:199-200, Jan 13, 2005. Correspondence

This article has been cited by other articles:

• Munkhaugen, J., Lydersen, S., Romundstad, P. R., Wideroe, T.-E., Vikse, B. E., Hallan, S. (2009). Kidney function and future risk for adverse pregnancy outcomes: a population-based study from HUNT II, Norway. Nephrol Dial Transplant 0: gfp320v1-gfp320 [Abstract] [Full Text]  
• Kripalani, M., Shawcross, J., Reilly, J., Main, J. (2009). Lithium and chronic kidney disease. BMJ 339: b2452-b2452 [Full Text]  
• Fujii, H., Nishijima, F., Goto, S., Sugano, M., Yamato, H., Kitazawa, R., Kitazawa, S., Fukagawa, M. (2009). Oral charcoal adsorbent (AST-120) prevents progression of cardiac damage in chronic kidney disease through suppression of oxidative stress. Nephrol Dial Transplant 24: 2089-2095 [Abstract] [Full Text]  
• Kastarinen, H., Horkko, S., Kauma, H., Karjalainen, A., Savolainen, M. J., Kesaniemi, Y. A. (2009). Low-density lipoprotein clearance in patients with chronic renal failure. Nephrol Dial Transplant 24: 2131-2135 [Abstract] [Full Text]  
• Parker, B. D., Ix, J. H., Cranenburg, E. C. M., Vermeer, C., Whooley, M. A., Schurgers, L. J. (2009). Association of kidney function and uncarboxylated matrix Gla protein: Data from the Heart and Soul Study. Nephrol Dial Transplant 24: 2095-2101 [Abstract] [Full Text]  
• Triverio, P.-A., Martin, P.-Y., Romand, J., Pugin, J., Perneger, T., Saudan, P. (2009). Long-term prognosis after acute kidney injury requiring renal replacement therapy. Nephrol Dial Transplant 24: 2186-2189 [Abstract] [Full Text]  
• Snyder, J. J., Collins, A. J. (2009). Association of Preventive Health Care with Atherosclerotic Heart Disease and Mortality in CKD. J. Am. Soc. Nephrol. 20: 1614-1622 [Abstract] [Full Text]  
• Weiner, D. E, Rifkin, D. E (2009). Kidney function and the risk of cardiovascular disease. BMJ 338: b1307-b1307 [Full Text]  
• Kurth, T., Jong, P. E d., Cook, N. R, Buring, J. E, Ridker, P. M (2009). Kidney function and risk of cardiovascular disease and mortality in women: a prospective cohort study. BMJ 338: b2392-b2392 [Abstract] [Full Text]  
• Einhorn, L. M., Zhan, M., Hsu, V. D., Walker, L. D., Moen, M. F., Seliger, S. L., Weir, M. R., Fink, J. C. (2009). The Frequency of Hyperkalemia and Its Significance in Chronic Kidney Disease. Arch Intern Med 169: 1156-1162 [Abstract] [Full Text]  
• Petersen, L. A., Woodard, L. D., Henderson, L. M., Urech, T. H., Pietz, K. (2009). Will Hypertension Performance Measures Used for Pay-for-Performance Programs Penalize Those Who Care for Medically Complex Patients?. Circulation 119: 2978-2985 [Abstract] [Full Text]  
• Hage, F. G., Venkataraman, R., Zoghbi, G. J., Perry, G. J., DeMattos, A. M., Iskandrian, A. E. (2009). The scope of coronary heart disease in patients with chronic kidney disease.. J Am Coll Cardiol 53: 2129-2140 [Abstract] [Full Text]  
• Lopes, N. H., da Silva Paulitsch, F., Pereira, A., Garzillo, C. L., Ferreira, J. F., Stolf, N., Hueb, W. (2009). Mild chronic kidney dysfunction and treatment strategies for stable coronary artery disease.. J. Thorac. Cardiovasc. Surg. 137: 1443-1449 [Abstract] [Full Text]  
• Phillips, L.A., Donovan, K.L., Phillips, A.O. (2009). Renal quality outcomes framework and eGFR: impact on secondary care. QJM 102: 415-423 [Abstract] [Full Text]  
• O'Callaghan, C.A. (2009). Chronic kidney disease--assessing the impact. QJM 102: 431-433 [Full Text]  
• Charytan, D. M., Wallentin, L., Lagerqvist, B., Spacek, R., De Winter, R. J., Stern, N. M., Braunwald, E., Cannon, C. P., Choudhry, N. K. (2009). Early Angiography in Patients with Chronic Kidney Disease: A Collaborative Systematic Review. CJASN 4: 1032-1043 [Abstract] [Full Text]  
• Windhausen, F., Hirsch, A., Fischer, J., van der Zee, P. M., Sanders, G. T., van Straalen, J. P., Cornel, J. H., Tijssen, J. G.P., Verheugt, F. W.A., de Winter, R. J., for the Invasive versus Conservative Treatment in, (2009). Cystatin C for Enhancement of Risk Stratification in Non-ST Elevation Acute Coronary Syndrome Patients with an Increased Troponin T. Clin. Chem. 55: 1118-1125 [Abstract] [Full Text]  
• Wong, G., Hayen, A., Chapman, J. R., Webster, A. C., Wang, J. J., Mitchell, P., Craig, J. C. (2009). Association of CKD and Cancer Risk in Older People. J. Am. Soc. Nephrol. 20: 1341-1350 [Abstract] [Full Text]  
• Anderson, S., Halter, J. B., Hazzard, W. R., Himmelfarb, J., Horne, F. M., Kaysen, G. A., Kusek, J. W., Nayfield, S. G., Schmader, K., Tian, Y., Ashworth, J. R., Clayton, C. P., Parker, R. P., Tarver, E. D., Woolard, N. F., High, K. P., for the workshop participants, (2009). Prediction, Progression, and Outcomes of Chronic Kidney Disease in Older Adults. J. Am. Soc. Nephrol. 20: 1199-1209 [Abstract] [Full Text]  
• Chan, J. C. N., Malik, V., Jia, W., Kadowaki, T., Yajnik, C. S., Yoon, K.-H., Hu, F. B. (2009). Diabetes in Asia: Epidemiology, Risk Factors, and Pathophysiology. JAMA 301: 2129-2140 [Abstract] [Full Text]  
• O'Hare, A. M., Kaufman, J. S., Covinsky, K. E., Landefeld, C. S., McFarland, L. V., Larson, E. B. (2009). Current Guidelines for Using Angiotensin-Converting Enzyme Inhibitors and Angiotensin II-Receptor Antagonists in Chronic Kidney Disease: Is the Evidence Base Relevant to Older Adults?. ANN INTERN MED 150: 717-724 [Abstract] [Full Text]  
• Gutierrez, O. M., Januzzi, J. L., Isakova, T., Laliberte, K., Smith, K., Collerone, G., Sarwar, A., Hoffmann, U., Coglianese, E., Christenson, R., Wang, T. J., deFilippi, C., Wolf, M. (2009). Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Chronic Kidney Disease. Circulation 119: 2545-2552 [Abstract] [Full Text]  
• Covic, A., Kothawala, P., Bernal, M., Robbins, S., Chalian, A., Goldsmith, D. (2009). Systematic review of the evidence underlying the association between mineral metabolism disturbances and risk of all-cause mortality, cardiovascular mortality and cardiovascular events in chronic kidney disease. Nephrol Dial Transplant 24: 1506-1523 [Abstract] [Full Text]  
• Ravera, M., Noberasco, G., Re, M., Filippi, A., Gallina, A. M., Weiss, U., Cannavo, R., Ravera, G., Cricelli, C., Deferrari, G. (2009). Chronic kidney disease and cardiovascular risk in hypertensive type 2 diabetics: a primary care perspective. Nephrol Dial Transplant 24: 1528-1533 [Abstract] [Full Text]  
• Parving, H.-H., Brenner, B. M., McMurray, John. J. V., de Zeeuw, D., Haffner, S. M., Solomon, S. D., Chaturvedi, N., Ghadanfar, M., Weissbach, N., Xiang, Z., Armbrecht, J., Pfeffer, M. A. (2009). Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE): rationale and study design. Nephrol Dial Transplant 24: 1663-1671 [Abstract] [Full Text]  
• Perico, N., Bravo, R. F., De Leon, F. R., Remuzzi, G. (2009). Screening for chronic kidney disease in emerging countries: feasibility and hurdles. Nephrol Dial Transplant 24: 1355-1358 [Full Text]  
• Foley, R. N., Wang, C., Snyder, J. J., Collins, A. J. (2009). Cystatin C Levels in U.S. Adults, 1988-1994 Versus 1999-2002: NHANES. CJASN 4: 965-972 [Abstract] [Full Text]  
• Yoshida, T., Kato, K., Fujimaki, T., Yokoi, K., Oguri, M., Watanabe, S., Metoki, N., Yoshida, H., Satoh, K., Aoyagi, Y., Nishigaki, Y., Tanaka, M., Nozawa, Y., Kimura, G., Yamada, Y. (2009). Association of Genetic Variants with Chronic Kidney Disease in Japanese Individuals. CJASN 4: 883-890 [Abstract] [Full Text]  
• Hsu, C.-y., Chertow, G. M., McCulloch, C. E., Fan, D., Ordonez, J. D., Go, A. S. (2009). Nonrecovery of Kidney Function and Death after Acute on Chronic Renal Failure. CJASN 4: 891-898 [Abstract] [Full Text]  
• Madero, M., Wassel, C. L., Peralta, C. A., Najjar, S. S., Sutton-Tyrrell, K., Fried, L., Canada, R., Newman, A., Shlipak, M. G., Sarnak, M. J., for the Health ABC Study, (2009). Cystatin C Associates with Arterial Stiffness in Older Adults. J. Am. Soc. Nephrol. 20: 1086-1093 [Abstract] [Full Text]  
• Connor, A (2009). Novel therapeutic agents and strategies for the management of chronic kidney disease mineral and bone disorder. Postgrad. Med. J. 85: 274-279 [Abstract] [Full Text]  
• Bell, M., Granath, F., Martensson, J., Lofberg, E., Ekbom, A., Martling, C.-R., of KING (Karolinska Intensive care Nephrology Grou, (2009). Cystatin C is correlated with mortality in patients with and without acute kidney injury. Nephrol Dial Transplant 0: gfp196v1-gfp196 [Abstract] [Full Text]  
• van Gestel, Y. R. B. M., Chonchol, M., Hoeks, S. E., Welten, G. M. J. M., Stam, H., Mertens, F. W., van Domburg, R. T., Poldermans, D. (2009). Association between chronic obstructive pulmonary disease and chronic kidney disease in vascular surgery patients. Nephrol Dial Transplant 0: gfp171v1-gfp171 [Abstract] [Full Text]  
• Kastarinen, H., Ukkola, O., Kesaniemi, Y. A. (2009). Glomerular filtration rate is related to carotid intima-media thickness in middle-aged adults. Nephrol Dial Transplant 0: gfp172v1-gfp172 [Abstract] [Full Text]  
• Koivuviita, N., Tertti, R., Jarvisalo, M., Pietila, M., Hannukainen, J., Sundell, J., Nuutila, P., Knuuti, J., Metsarinne, K. (2009). Increased basal myocardial perfusion in patients with chronic kidney disease without symptomatic coronary artery disease. Nephrol Dial Transplant 0: gfp175v1-gfp175 [Abstract] [Full Text]  
• Yokoyama, H., Sone, H., Oishi, M., Kawai, K., Fukumoto, Y., Kobayashi, M., on behalf of Japan Diabetes Clinical Data Manageme, (2009). Prevalence of albuminuria and renal insufficiency and associated clinical factors in type 2 diabetes: the Japan Diabetes Clinical Data Management study (JDDM15). Nephrol Dial Transplant 24: 1212-1219 [Abstract] [Full Text]  
• Pizzarelli, F., Lauretani, F., Bandinelli, S., Windham, G. B., Corsi, A. M., Giannelli, S. V., Ferrucci, L., Guralnik, J. M. (2009). Predictivity of survival according to different equations for estimating renal function in community-dwelling elderly subjects. Nephrol Dial Transplant 24: 1197-1205 [Abstract] [Full Text]  
• Reinecke, H., Brand, E., Mesters, R., Schabitz, W.-R., Fisher, M., Pavenstadt, H., Breithardt, G. (2009). Dilemmas in the Management of Atrial Fibrillation in Chronic Kidney Disease. J. Am. Soc. Nephrol. 20: 705-711 [Abstract] [Full Text]  
• van der Velde, M., Halbesma, N., de Charro, F. T., Bakker, S. J.L., de Zeeuw, D., de Jong, P. E., Gansevoort, R. T. (2009). Screening for Albuminuria Identifies Individuals at Increased Renal Risk. J. Am. Soc. Nephrol. 20: 852-862 [Abstract] [Full Text]  
• Noiri, E., Doi, K., Negishi, K., Tanaka, T., Hamasaki, Y., Fujita, T., Portilla, D., Sugaya, T. (2009). Urinary fatty acid-binding protein 1: an early predictive biomarker of kidney injury. Am. J. Physiol. Renal Physiol. 296: F669-F679 [Abstract] [Full Text]  
• Koleganova, N., Piecha, G., Ritz, E., Schirmacher, P., Muller, A., Meyer, H.-P., Gross, M.-L. (2009). Arterial calcification in patients with chronic kidney disease. Nephrol Dial Transplant 0: gfp137v1-gfp137 [Abstract] [Full Text]  
• Go, A. S., Fang, M. C., Udaltsova, N., Chang, Y., Pomernacki, N. K., Borowsky, L., Singer, D. E., for the ATRIA Study Investigators, (2009). Impact of Proteinuria and Glomerular Filtration Rate on Risk of Thromboembolism in Atrial Fibrillation: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. Circulation 119: 1363-1369 [Abstract] [Full Text]  
• Peralta, C. A., Katz, R., Madero, M., Sarnak, M., Kramer, H., Criqui, M. H., Shlipak, M. G. (2009). The Differential Association of Kidney Dysfunction With Small and Large Arterial Elasticity: The Multiethnic Study of Atherosclerosis. Am J Epidemiol 169: 740-748 [Abstract] [Full Text]  
• Diez, C., Mohr, P., Kuss, O., Osten, B., Silber, R.-E., Hofmann, H.-S. (2009). Impact of Preoperative Renal Dysfunction on In-hospital Mortality After Solitary Valve and Combined Valve and Coronary Procedures.. Ann. Thorac. Surg. 87: 731-736 [Abstract] [Full Text]  
• Asselbergs, F. W., Mozaffarian, D., Katz, R., Kestenbaum, B., Fried, L. F., Gottdiener, J. S., Shlipak, M. G., Siscovick, D. S. (2009). Association of renal function with cardiac calcifications in older adults: the cardiovascular health study. Nephrol Dial Transplant 24: 834-840 [Abstract] [Full Text]  
• Thilly, N., Boini, S., Kessler, M., Briancon, S., Frimat, L. (2009). Management and control of hypertension and proteinuria in patients with advanced chronic kidney disease under nephrologist care or not: data from the AVENIR study (AVantagE de la Nephroprotection dans l'Insuffisance Renale). Nephrol Dial Transplant 24: 934-939 [Abstract] [Full Text]  
• Poggio, E. D., Rule, A. D. (2009). A critical evaluation of chronic kidney disease--should isolated reduced estimated glomerular filtration rate be considered a 'disease'?. Nephrol Dial Transplant 24: 698-700 [Full Text]  
• Sanchez-Villanueva, R., Bajo, A., del Peso, G., Fernandez-Reyes, M-J., Gonzalez, E., Romero, S., Estrada, P., Selgas, R. (2009). Higher daily peritoneal protein clearance when initiating peritoneal dialysis is independently associated with peripheral arterial disease (PAD): A possible new marker of systemic endothelial dysfunction?. Nephrol Dial Transplant 24: 1009-1014 [Abstract] [Full Text]  
• Patel, P. C., Ayers, C. R., Murphy, S. A., Peshock, R., Khera, A., de Lemos, J. A., Balko, J. A., Gupta, S., Mammen, P. P.A., Drazner, M. H., Markham, D. W. (2009). Association of Cystatin C With Left Ventricular Structure and Function: The Dallas Heart Study. Circ Heart Fail 2: 98-104 [Abstract] [Full Text]  
• Gansevoort, R. T., de Jong, P. E. (2009). The Case for Using Albuminuria in Staging Chronic Kidney Disease. J. Am. Soc. Nephrol. 20: 465-468 [Full Text]  
• Sim, J. J., Rasgon, S. A., Kujubu, D. A., Kumar, V. A., Liu, I. L. A., Shi, J. M., Pham, T. T., Derose, S. F. (2009). Sleep Apnea in Early and Advanced Chronic Kidney Disease: Kaiser Permanente Southern California Cohort. Chest 135: 710-716 [Abstract] [Full Text]  
• Carrero, J. J., Qureshi, A. R., Parini, P., Arver, S., Lindholm, B., Barany, P., Heimburger, O., Stenvinkel, P. (2009). Low Serum Testosterone Increases Mortality Risk among Male Dialysis Patients. J. Am. Soc. Nephrol. 20: 613-620 [Abstract] [Full Text]  
• Szczech, L. A., Harmon, W., Hostetter, T. H., Klotman, P. E., Powe, N. R., Sedor, J. R., Smedberg, P., Himmelfarb, J. (2009). World Kidney Day 2009: Problems and Challenges in the Emerging Epidemic of Kidney Disease. J. Am. Soc. Nephrol. 20: 453-455 [Full Text]  
• Agarwal, R., Alborzi, P., Satyan, S., Light, R. P. (2009). Dry-Weight Reduction in Hypertensive Hemodialysis Patients (DRIP): A Randomized, Controlled Trial. Hypertension 53: 500-507 [Abstract] [Full Text]  
• Hsu, C.-y., Iribarren, C., McCulloch, C. E., Darbinian, J., Go, A. S. (2009). Risk Factors for End-Stage Renal Disease: 25-Year Follow-up. Arch Intern Med 169: 342-350 [Abstract] [Full Text]  
• Damman, K., van Deursen, V. M., Navis, G., Voors, A. A., van Veldhuisen, D. J., Hillege, H. L. (2009). Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease.. J Am Coll Cardiol 53: 582-588 [Abstract] [Full Text]  
• NEOGI, T., ELLISON, R. C., HUNT, S., TERKELTAUB, R., FELSON, D. T., ZHANG, Y. (2009). Serum Uric Acid Is Associated with Carotid Plaques: The National Heart, Lung, and Blood Institute Family Heart Study. The Journal of Rheumatology 36: 378-384 [Abstract] [Full Text]  
• Keller, T., Messow, C. M., Lubos, E., Nicaud, V., Wild, P. S., Rupprecht, H. J., Bickel, C., Tzikas, S., Peetz, D., Lackner, K. J., Tiret, L., Munzel, T. F., Blankenberg, S., Schnabel, R. B. (2009). Cystatin C and cardiovascular mortality in patients with coronary artery disease and normal or mildly reduced kidney function: results from the AtheroGene study. Eur Heart J 30: 314-320 [Abstract] [Full Text]  
• Agrawal, V., Ghosh, A. K., Barnes, M. A., McCullough, P. A. (2009). Perception of Indications for Nephrology Referral among Internal Medicine Residents: A National Online Survey. CJASN 4: 323-328 [Abstract] [Full Text]  
• den Hartog, J. R., Reese, P. P., Cizman, B., Feldman, H. I. (2009). The Costs and Benefits of Automatic Estimated Glomerular Filtration Rate Reporting. CJASN 4: 419-427 [Abstract] [Full Text]  
• Cheung, C. K., Bhandari, S. (2009). Perspectives on eGFR reporting from the Interface between Primary and Secondary Care. CJASN 4: 258-260 [Abstract] [Full Text]  
• Isakova, T., Gutierrez, O. M., Chang, Y., Shah, A., Tamez, H., Smith, K., Thadhani, R., Wolf, M. (2009). Phosphorus Binders and Survival on Hemodialysis. J. Am. Soc. Nephrol. 20: 388-396 [Abstract] [Full Text]  
• Shroff, R. (2009). MONITORING CARDIOVASCULAR RISK FACTORS IN CHILDREN ON DIALYSIS. pdi 29: S173-S175 [Abstract] [Full Text]  
• Razzaque, M. S. (2009). Does FGF23 toxicity influence the outcome of chronic kidney disease?. Nephrol Dial Transplant 24: 4-7 [Full Text]  
• Kobayashi, M., Hirawa, N., Yatsu, K., Kobayashi, Y., Yamamoto, Y., Saka, S., Andoh, D., Toya, Y., Yasuda, G., Umemura, S. (2009). Relationship between silent brain infarction and chronic kidney disease. Nephrol Dial Transplant 24: 201-207 [Abstract] [Full Text]  
• Moranne, O., Froissart, M., Rossert, J., Gauci, C., Boffa, J.-J., Haymann, J. P., M'rad, M. B., Jacquot, C., Houillier, P., Stengel, B., Fouqueray, B., the NephroTest Study Group, (2009). Timing of Onset of CKD-Related Metabolic Complications. J. Am. Soc. Nephrol. 20: 164-171 [Abstract] [Full Text]  
• Deji, N., Kume, S., Araki, S.-i., Soumura, M., Sugimoto, T., Isshiki, K., Chin-Kanasaki, M., Sakaguchi, M., Koya, D., Haneda, M., Kashiwagi, A., Uzu, T. (2009). Structural and functional changes in the kidneys of high-fat diet-induced obese mice. Am. J. Physiol. Renal Physiol. 296: F118-F126 [Abstract] [Full Text]  
• Ninomiya, T., Kiyohara, Y., Tokuda, Y., Doi, Y., Arima, H., Harada, A., Ohashi, Y., Ueshima, H., for the Japan Arteriosclerosis Longitudinal Study, (2008). Impact of Kidney Disease and Blood Pressure on the Development of Cardiovascular Disease: An Overview From the Japan Arteriosclerosis Longitudinal Study. Circulation 118: 2694-2701 [Abstract] [Full Text]  
• Hakeem, A., Bhatti, S., Dillie, K. S., Cook, J. R., Samad, Z., Roth-Cline, M. D., Chang, S. M. (2008). Predictive Value of Myocardial Perfusion Single-Photon Emission Computed Tomography and the Impact of Renal Function on Cardiac Death. Circulation 118: 2540-2549 [Abstract] [Full Text]  
• Go, A. S., Yang, J., Gurwitz, J. H., Hsu, J., Lane, K., Platt, R. (2008). Comparative Effectiveness of Different {beta}-Adrenergic Antagonists on Mortality Among Adults With Heart Failure in Clinical Practice. Arch Intern Med 168: 2415-2421 [Abstract] [Full Text]  
• Saran, A. M., DuBose, T. D. Jr (2008). Cardiovascular disease in chronic kidney disease. Ther Adv Cardiovasc Dis 2: 425-434 [Abstract]  
• Rambod, M., Kovesdy, C. P, Bross, R., Kopple, J. D, Kalantar-Zadeh, K. (2008). Association of serum prealbumin and its changes over time with clinical outcomes and survival in patients receiving hemodialysis. Am. J. Clin. Nutr. 88: 1485-1494 [Abstract] [Full Text]  
• Brantsma, A. H., Bakker, S. J. L., Hillege, H. L., de Zeeuw, D., de Jong, P. E., Gansevoort, R. T., for the PREVEND Study Group, (2008). Cardiovascular and renal outcome in subjects with K/DOQI stage 1-3 chronic kidney disease: the importance of urinary albumin excretion. Nephrol Dial Transplant 23: 3851-3858 [Abstract] [Full Text]  
• Silva, J., Ridao-Cano, N., Segura, A., Maroto, L. C., Cobiella, J., Carnero, M., Barrientos, A., Rodriguez, J. E. (2008). Can estimated glomerular filtration rate improve the EuroSCORE?. ICVTS 7: 1054-1057 [Abstract] [Full Text]  
• Murtagh, F. E. M., Murphy, E., Sheerin, N. S. (2008). Illness trajectories: an important concept in the management of kidney failure. Nephrol Dial Transplant 23: 3746-3748 [Full Text]  
• Radbill, B., Murphy, B., LeRoith, D. (2008). Rationale and Strategies for Early Detection and Management of Diabetic Kidney Disease. Mayo Clin Proc. 83: 1373-1381 [Abstract] [Full Text]  
• Fukuda, M., Mizuno, M., Yamanaka, T., Motokawa, M., Shirasawa, Y., Nishio, T., Miyagi, S., Yoshida, A., Kimura, G. (2008). Patients With Renal Dysfunction Require a Longer Duration Until Blood Pressure Dips During the Night. Hypertension 52: 1155-1160 [Abstract] [Full Text]  
• James, M. T., Laupland, K. B., Tonelli, M., Manns, B. J., Culleton, B. F., Hemmelgarn, B. R., for the Alberta Kidney Disease Network, (2008). Risk of Bloodstream Infection in Patients With Chronic Kidney Disease Not Treated With Dialysis. Arch Intern Med 168: 2333-2339 [Abstract] [Full Text]  
• Levin, A. MD, Hemmelgarn, B. MD PhD, Culleton, B. MD MSc, Tobe, S. MD, McFarlane, P. MD PhD, Ruzicka, M. MD PhD, Burns, K. MD, Manns, B. MD MSc, White, C. MD, Madore, F. MD MSc, Moist, L. MD MSc, Klarenbach, S. MD MSc, Barrett, B. MD MSc, Foley, R. MD MSc, Jindal, K. MD, Senior, P. MBBS PhD, Pannu, N. MD MSc, Shurraw, S. MD, Akbari, A. MD, Cohn, A. MD, Reslerova, M. MD PhD, Deved, V. MD, Mendelssohn, D. MD, Nesrallah, G. MD, Kappel, J. MD, Tonelli, M. MD SM, for the Canadian Society of Nephrology, (2008). Guidelines for the management of chronic kidney disease. CMAJ 179: 1154-1162 [Full Text]  
• Ronco, C., Haapio, M., House, A. A., Anavekar, N., Bellomo, R. (2008). Cardiorenal Syndrome. J Am Coll Cardiol 52: 1527-1539 [Abstract] [Full Text]  
• Fox, C. H., Swanson, A., Kahn, L. S., Glaser, K., Murray, B. M. (2008). Improving Chronic Kidney Disease Care in Primary Care Practices: An Upstate New York Practice-based Research Network (UNYNET) Study. J Am Board Fam Med 21: 522-530 [Abstract] [Full Text]